コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 confidence interval [CI]: 1.81 to 2.36) for VLDL cholesterol, 1.19 (95% CI: 1.14 to 1.25) for VLDL t
2 es (+58 mg/dL), LDL cholesterol (+11 mg/dL), VLDL cholesterol (+8 mg/dL), glucose (+9 mg/dL), systoli
5 reased LDL and HDL cholesterol but increased VLDL cholesterol and no significant difference in extent
7 accounted for major variations in plasma LDL/VLDL cholesterol and triglyceride levels, coincided with
9 BMI, systolic and diastolic blood pressure, VLDL cholesterol, and glucose parameters were higher in
10 hanges in concentrations of HDL cholesterol, VLDL cholesterol, and triglyceride, but not LDL choleste
11 sma TC, LDL-C, very-low-density lipoprotein (VLDL) cholesterol, and MDA than had the PC group after 8
12 er remnant and very-low-density lipoprotein (VLDL) cholesterol, but there were no associations on cho
13 low-density lipoprotein (VLDL)-lipoproteins, VLDL-cholesterol (C), VLDL-triglycerides, VLDL-diameter,
14 on dramatically decreased plasma VLDL TG and VLDL cholesterol concentrations but only moderately incr
15 ts reduce fasting plasma triacylglycerol and VLDL-cholesterol concentrations by 19% and 22%, respecti
16 more marked reduction in triacylglycerol and VLDL-cholesterol concentrations in subjects who consumed
17 sity-lipoprotein (VLDL) triacylglycerol, and VLDL-cholesterol concentrations were higher (P < 0.05-0.
18 entrations were adjusted for HDL-, LDL-, and VLDL-cholesterol concentrations, we calculated partial S
19 KO mice also exhibited higher plasma LDL and VLDL cholesterol content, increased circulating apolipop
23 ficantly increased the hepatic production of VLDL-cholesterol fourfold, VLDL-triglyceride two and one
24 irst 6 months with respect to triglycerides, VLDL cholesterol, insulin, C peptide, and uric acid; the
25 erol level, high LDL cholesterol level, high VLDL cholesterol level, high triglyceride level, high to
26 ol level, high very low-density lipoprotein (VLDL) cholesterol level, high triglyceride level, low hi
28 tivation of Bmal1 led to elevated plasma LDL/VLDL cholesterol levels as a consequence of the disrupti
31 otal plasma cholesterol, LDL-cholesterol and VLDL-cholesterol levels, as well as obesity measures (bo
34 ocardial infarction entered by importance as VLDL cholesterol, systolic blood pressure, smoking, and
35 ity lipoprotein cholesterol (LDL cholesterol/VLDL cholesterol-TBARS) as indicators of lipid peroxidat
36 omen had an increased likelihood of elevated VLDL cholesterol, triacylglycerol, diastolic blood press
37 endothelial function, or total cholesterol, VLDL-cholesterol, triacylglycerol, apolipoprotein B, or
40 olesterol, and very-low-density-lipoprotein (VLDL)-cholesterol values were significantly lower than i
42 ) cholesterol, very-low-density-lipoprotein (VLDL) cholesterol, VLDL3 cholesterol, lipoprotein(a), an